{"url_path":"/sec/cik-0001900520/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","accession_number":"0001213900-26-057605","cik":"0001900520","ticker":null,"issuer_name":"Lomond Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1900520/0001213900-26-057605-index.html","primary_entity_key":"0001900520","primary_entity_name":"Lomond Therapeutics Holdings, Inc."},"word_count":97,"has_tables":true,"body_markdown":"**Item 1. Legal Proceedings**\n\n \n\nWe are not currently a party to any legal proceedings,\nlitigation or claims, nor are aware of any pending, threatened, or unasserted claims, which, if determined adversely to us, would have\na material adverse effect on our business, financial condition, results of operations or cash flows. We may from time to time, be a party\nto litigation and subject to claims incident to the ordinary course of business. Regardless of the outcome, litigation can have an adverse\nimpact on us because of defense and settlement costs, diversion of management resources, and other factors."}